Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
208.84
-6.14 (-2.86%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,151,112
Open
213.99
Bid (Size)
208.10 (100)
Ask (Size)
209.00 (200)
Prev. Close
214.98
Today's Range
207.71 - 214.56
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.31%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
Today 9:51 EDT
By Financial Research Feature April 3, 2026 Introduction In the high-stakes arena of global biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has long stood as a paragon of scientific...
Via
Finterra
Topics
Economy
Intellectual Property
World Trade
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
↗
April 02, 2026
Dividend payers might become more popular if the recent volatility continues. These two stocks are great picks to weather the storm.
Via
The Motley Fool
Topics
Economy
Retirement
Stocks
Performance
YTD
-8.9%
-8.9%
1 Month
-10.7%
-10.7%
3 Month
-8.9%
-8.9%
6 Month
-11.7%
-11.7%
1 Year
+1.8%
+1.8%
More News
Read More
Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
April 02, 2026
Via
MarketMinute
Topics
Intellectual Property
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
April 02, 2026
Via
StockStory
Topics
Government
Stocks
World Trade
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
April 01, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
Via
MarketMinute
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
March 31, 2026
Via
MarketMinute
Topics
ETFs
Intellectual Property
Stocks
Merck Just Made a Big Bet on a New Cancer Growth Engine
↗
March 31, 2026
Via
MarketBeat
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
↗
March 30, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
1 Reason Eli Lilly Stock Is Still a Buy
↗
March 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends
↗
March 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
March 26, 2026
Via
Finterra
Topics
Cannabis
Initial Public Offering
Intellectual Property
The Fed Is Worried About Trump-Fueled Inflation. Are Your Stocks Safe?
↗
March 25, 2026
Via
The Motley Fool
Topics
Economy
Government
World Trade
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
↗
March 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via
MarketMinute
Topics
Economy
Initial Public Offering
Intellectual Property
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now
↗
March 23, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
Best Healthcare Stocks to Buy After the Market Pullback
↗
March 20, 2026
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $2,000 Right Now
↗
March 20, 2026
Via
The Motley Fool
Topics
Energy
Intellectual Property
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Top S&P500 movers in Wednesday's session
↗
March 18, 2026
Via
Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
↗
March 18, 2026
Via
Chartmill
What's Going On With AbbVie Stock Today?
↗
March 18, 2026
Via
Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index
↗
March 18, 2026
Via
Chartmill
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 208.84
When was AbbVie last traded?
The last trade of AbbVie was at 04/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.